Previous researches had confirmed the expression of VEGF was increased in many cancers, including colon cancer (15), lung cancer (16), breast cancer (17), and gastric cancer (18), which indicated the poor survival for patients. This evidence concerns the gene VEGFA and colonic neoplasm.